CD14 and Crohn disease: Decreased percentage of anti-inflammatory non-classical CD14+CD16++ monocytes in non-biologically treated Crohn’s disease and their unchanged level after biological therapy indicate the higher potential of intestinal wound healing in biologically treated patients.